{"id":"https://openalex.org/W2082257674","doi":"https://doi.org/10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","title":"Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial","display_name":"Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial","publication_year":1978,"publication_date":"1978-12-01","ids":{"openalex":"https://openalex.org/W2082257674","doi":"https://doi.org/10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","mag":"2082257674","pmid":"https://pubmed.ncbi.nlm.nih.gov/365313"},"language":"en","primary_location":{"id":"doi:10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","doi":"https://doi.org/10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004840750","display_name":"Rowan T. Chlebowski","orcid":"https://orcid.org/0000-0002-4212-6184","observed_orcids":["https://orcid.org/0000-0002-4212-6184"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rowan T. Chlebowski","raw_affiliation_strings":["Western Cancer Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Cancer Study Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084661962","display_name":"Robert Hestorff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Hestorff","raw_affiliation_strings":["Western Cancer Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Cancer Study Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023048288","display_name":"Leonard Sardoff","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonard Sardoff","raw_affiliation_strings":["Western Cancer Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Cancer Study Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004903945","display_name":"John M. Weiner","orcid":"https://orcid.org/0000-0001-5895-8973","observed_orcids":["https://orcid.org/0000-0001-5895-8973"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Weiner","raw_affiliation_strings":["Western Cancer Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Cancer Study Group","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109105626","display_name":"Joseph R. Bateman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph R. Bateman","raw_affiliation_strings":["Western Cancer Study Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Cancer Study Group","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.7145,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.82571996,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"42","issue":"6","first_page":"2546","last_page":"2552"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-prostate-cancer","display_name":"metastatic prostate cancer","score":0.7910000085830688},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9829999804496765},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8939999938011169},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9559999704360962},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.906000018119812},{"id":"https://openalex.org/keywords/chemotherapy-efficacy","display_name":"chemotherapy efficacy","score":0.4569999873638153},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.9430000185966492},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.925000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8771184086799622},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.8589684367179871},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.7379137277603149},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5186442732810974},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4283809959888458},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41931912302970886},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4018487334251404},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.34469327330589294}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004064","descriptor_name":"Digestive System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","doi":"https://doi.org/10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","is_oa":false,"landing_page_url":"https://doi.org/10.1002/1097-0142(197812)42:6<2546::aid-cncr2820420607>3.0.co;2-c","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:365313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/365313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1845460725","https://openalex.org/W1981472668","https://openalex.org/W2079088649","https://openalex.org/W2278220001","https://openalex.org/W2406607853","https://openalex.org/W2467523950","https://openalex.org/W4249115674"],"related_works":["https://openalex.org/W2001540529","https://openalex.org/W2423207070","https://openalex.org/W2087122908","https://openalex.org/W2407255983","https://openalex.org/W2262614791","https://openalex.org/W2027909591","https://openalex.org/W2467523950","https://openalex.org/W2438249790","https://openalex.org/W2408940427","https://openalex.org/W2402513649"],"abstract_inverted_index":{"Twenty-seven":[0],"patients":[1,105,128,138,181],"with":[2,18,70,159,182,191],"a":[3,14,22,64,87],"diagnosis":[4],"of":[5,8,24,89,100,109,127,137,175,197,203],"metastatic":[6],"adenocarcinoma":[7],"the":[9,77,90,101,110,121,125,141,164,173],"prostate":[10],"were":[11,30],"treated":[12,104,113],"in":[13,98,107,120,163,206],"randomized,":[15],"prospective":[16],"trial":[17],"either":[19,31],"Cyclophosphamide":[20,32,41,103,131,167],"or":[21,40],"combination":[23,112,142,174],"Adriamycin,":[25],"5-Fluorouracil,":[26],"and":[27,106,154,178],"Cyclophosphamide.":[28],"Doses":[29],"alone":[33,168],"(800-1200":[34],"mg/m2":[35,43,50,58],"iv":[36,51,59],"q":[37],"3":[38],"weeks)":[39],"(150-200":[42],"po":[44],"Day":[45,52,60],"3-6)":[46],"plus":[47,55],"5-FU":[48,177],"(400-500":[49],"1,":[53],"8)":[54],"Adriamycin":[56,179],"(30-50":[57],"1)":[61],"given":[62],"as":[63,84,170,172],"4":[65],"week":[66],"treatment":[67],"cycle.":[68],"Patients":[69],"compromised":[71],"bone":[72],"marrow":[73],"reserve":[74],"initially":[75],"received":[76],"lower":[78],"dose":[79],"level.":[80],"Objectively":[81],"stable":[82],"disease":[83],"defined":[85],"by":[86],"modification":[88],"National":[91],"Prostatic":[92],"Cancer":[93],"Project":[94],"criteria":[95],"was":[96,116,132,157,169],"seen":[97],"53%":[99],"15":[102],"50%":[108],"12":[111],"patients.":[114],"Survival":[115],"not":[117],"significantly":[118,133],"different":[119],"two":[122],"arms.":[123],"However,":[124],"survival":[126],"responding":[129,139],"to":[130,140],"longer":[134],"than":[135,151],"that":[136],"(median":[143],"18.6":[144],"months":[145],"versus":[146],"8.1":[147],"months,":[148],"p":[149],"less":[150],"0.05).":[152],"Gastrointestinal":[153],"hematologic":[155,188],"toxicity":[156,189],"moderate":[158,187],"both":[160,192],"regimens.":[161],"Therefore,":[162],"present":[165],"study,":[166],"effective":[171],"Cyclophosphamide,":[176],"for":[180],"disseminated":[183],"prostatic":[184],"carcinoma.":[185],"The":[186],"noted":[190],"regimens":[193],"suggests":[194],"further":[195],"evaluation":[196],"drug":[198],"combinations":[199],"utilizing":[200],"higher":[201],"dosages":[202],"active":[204],"agents":[205],"this":[207],"disease.":[208]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
